ENTITY

Medicines Company (MDCO US)

Health CareUnited States
The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
more
Publication Icon
No publications yet
There aren’t any Insights right now
Back to "All"
x